Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2023-08-10 00:00:00 ET · period of report 2023-08-09 · accession 0001209191-23-045303 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-10 | 2023-08-09 | APVO | Kunz Barbara Lopez | Dir | M - OptEx | — | +3,571 | 4,880 | +273% | — |
| D | 2023-08-10 | 2023-08-09 | APVO | Kunz Barbara Lopez | Dir | M - OptEx | $0.00 | -3,571 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-09 | M | A | 3,571 | — | 4,880 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2023-08-09 | M | D | 3,571 | $0.00 | 0 | D | — · — to — | 3,571 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant. |